-
Mashup Score: 63The 5th Annual OncoAlert Colloquium - 16 hour(s) ago
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Source: oncoalert.m-pages.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 12Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy - 1 day(s) ago
Colorectal cancer (CRC) remains a major global health burden, being one of the most prevalent cancers with high mortality rates. Despite advances in conventional treatment modalities, patients with metastatic CRC often face limited options and poor …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
RT @Erman_Akkus: 🧫CAR-T cells in CRC ⁉️Potential as a treatment option? https://t.co/nRJvgNgQRw @OncoAlert @ASCO @JCO_ASCO #cancer #onc…
-
-
Mashup Score: 8
Experts said Durvalumab could be a ‘game changer’.
Source: www.independent.co.ukCategories: General Medicine News, Oncologists1Tweet-
RT @drenriquegrande: ‘Increased survival rates’ for bladder cancer patients given immunotherapy drug https://t.co/QYRhxRcoqq @ProfSyedHussa…
-
-
Mashup Score: 1
This trial compared investigational hand therapy intervention with a traditional occupational therapy approach to prevent chemotherapy-induced peripheral n
Source: academic.oup.comCategories: General Medicine News, Oncologists1Tweet-
RT @realbowtiedoc: @OncJournal @OncoAlert @PallOncCoP 🔗: https://t.co/LPlquaUayd
-
-
Mashup Score: 12Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy - 1 day(s) ago
Colorectal cancer (CRC) remains a major global health burden, being one of the most prevalent cancers with high mortality rates. Despite advances in conventional treatment modalities, patients with metastatic CRC often face limited options and poor …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
RT @Erman_Akkus: 🧫CAR-T cells in CRC ⁉️Potential as a treatment option? https://t.co/nRJvgNgQRw @OncoAlert @ASCO @JCO_ASCO #cancer #onc…
-
-
Mashup Score: 8
Experts said Durvalumab could be a ‘game changer’.
Source: www.independent.co.ukCategories: General Medicine News, Oncologists1Tweet-
RT @drenriquegrande: ‘Increased survival rates’ for bladder cancer patients given immunotherapy drug https://t.co/QYRhxRcoqq @ProfSyedHussa…
-
-
Mashup Score: 24APCCC Diagnostics 2025 - APCCC - 2 day(s) ago
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth. The introduction of the Advanced Prostate Cancer Consensus Conference (APCCC) in 2015 represents a milestone of establishing clinical consensus in the
Source: apccc.orgCategories: General Medicine News, Oncologists1Tweet-
Dear Colleagues A warm invitation to JOIN US at #APCCCDiagnostics25 A HYBRID Meeting (In Person & Live) in Lugano Switzerland February 27-28, 2025 REGISTER: https://t.co/liXpdhy66c Enjoy Early Bird Registration, NOW OPEN ONLINE REGISTRATION FOR LMIC's FREE‼️ OncoAlert 🚨Will… https://t.co/UyKObpyq07 https://t.co/pPhDUcVQN5
-
-
Mashup Score: 1The OncoAlert Newsletter is NOW OUT Click to Register - 2 day(s) ago
The OncoAlert Newsletter is now out for June 23-29, 2023
Source: www.OncoAlert360.comCategories: General Medicine News, Onc News and JournalsTweet-
RT @BenWestphalen: Out today 💥 The new @OncoAlert 🚨 #newsletter - if you don’t want to miss out: register at https://t.co/AxMKHsMAQC 🌐
-
-
Mashup Score: 10SABCS24 ONCOALERT | ONCOBITES - 2 day(s) ago
In an interview, Dr. Agostinetto delves into the findings of Dr. Souza, who shares the results of his research explaining why larotrectinib is positioned as an effective and safe treatment option for patients with TRK fusion breast cancer. Dr. Cristiano de P á dua Souza MD, Jules Bordet Institute, Brussels,
Source: www.oncobites.tvCategories: General Medicine News, Oncologists1Tweet-
Join our collaborators at @OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer #SABCS24 Link to view: https://t.co/IHi0sALPjO Dr. @ElisaAgostinett Elisa Agostinetto from the Jules… https://t.co/6JvXP1Kh33 https://t.co/wmD1obxNaJ
-
-
Mashup Score: 7Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells - 2 day(s) ago
CAR signaling domains determine molecular dynamics at the immune synapse and consequently influence CAR T cell killing behavior.
Source: www.science.orgCategories: General Medicine News, Oncologists1Tweet-
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma out on Science Advances https://t.co/PqChMFOvkQ This study explores the differences in tumor rejection kinetics between CD28.ζ and 4-1BB.ζ chimeric… https://t.co/bqLVIjBfY5 https://t.co/OtpP0yjCXE
-
The #OncoAlertColloquium 🚨Returns for its 5⃣th year The Year in Oncology 2024 with⚕️TOP Oncology Faculty and TOP Oncology Partners that will give this meeting a TRUE Interdisciplinary approach‼️ Registration is NOW OPEN LINK: https://t.co/IZgVZxwIYp See you soon! The Network… https://t.co/841qvpmNCz https://t.co/4Sz69h68aJ